ARCHIVES

In Brief: Bogardus Heads ASTRO, Million President Elect; Woods Named Chief of NIC Contracts Review

This article is from The Cancer Letter archive.

Vol. 15 No. 41 | October 27, 1989

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

Dingell Subcommittee Report Next Month To Include New Info

July 1, 1994

Funding Opportunities: NIAID seeks New Investigator, Risky Research Proposals

March 28, 1997

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

Smokeless Tobacco Warning Bill May Go To House Floor

January 24, 1986